A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas. This is an ASCO ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed. Summary: Tocilizumab is a novel monoclonal antibody that ...

Interleukin (IL)-6 has emerged as a potential new target in the treatment of renal disease in patients with systemic lupus erythematosus (SLE), according to a report by Hannes Cash et al.

It is well documented that hepcidin plays a key role in anaemia of chronic inflammatory diseases. IL-6 induces the secretion of hepcidin, an iron regulatory peptide hormone that is produced in the ...

A dietitian has shared the exact reason some endometriosis symptoms are getting worse and what you can do to help ease them.

A new clinical study from Cardiff Metropolitan University – in collaboration with Cwm Taf Morgannwg University Health Board ...

Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...

Launching its public consultation yesterday, the chair of the non-statutory inquiry, Prof Anne Scott, said it will be largely ...

Acute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology.

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...